Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.54% |
| 2 | Financials | 9.27% |
| 3 | Industrials | 6.9% |
| 4 | Healthcare | 6.27% |
| 5 | Consumer Discretionary | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Acuity Brands
AYI
$10.7B
| $8.41M | ﹤0.01% |
28,202
-23,213
| -45% | -$6.01M |
|
2002
Calumet Specialty Products
CLMT
$4.05B
| $8.41M | ﹤0.01% |
534,021
-8,332
| -2% | -$106K |
|
2003
Tortoise North American Pipeline ETF
TPYP
$868M
| $8.35M | ﹤0.01% |
233,629
+4,943
| +2% | +$173K |
|
2004
TRI-Continental Corp
TY
$1.9B
| $8.34M | ﹤0.01% |
263,482
+3,857
| +1% | +$117K |
|
2005
Ionis Pharmaceuticals
IONS
$9.21B
| $8.32M | ﹤0.01% |
210,592
+61,902
| +42% | +$2.03M |
|
2006
FT Vest International Equity Moderate Buffer ETF March
YMAR
$164M
| $8.31M | ﹤0.01% |
325,909
-62,640
| -16% | -$1.54M |
|
2007
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$2.23B
| $8.3M | ﹤0.01% |
82,238
+10,015
| +14% | +$1M |
|
2008
iShares Convertible Bond ETF
ICVT
$7.44B
| $8.29M | ﹤0.01% |
92,001
-7,792
| -8% | -$668K |
|
|
RWT
2009
Redwood Trust
RWT
$588M
| $8.29M | ﹤0.01% |
1,402,097
-265,043
| -16% | -$1.51M |
|
2010
AtriCure
ATRC
$2.18B
| $8.28M | ﹤0.01% |
252,523
+5,087
| +2% | +$165K |
|
2011
Commercial Metals
CMC
$7.97B
| $8.27M | ﹤0.01% |
168,985
+3,850
| +2% | +$178K |
|
2012
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.73B
| $8.26M | ﹤0.01% |
134,189
-9,142
| -6% | -$534K |
|
2013
Nuveen Credit Strategies Income Fund
JQC
$717M
| $8.26M | ﹤0.01% |
1,532,147
-79,065
| -5% | -$414K |
|
2014
Progress Software
PRGS
$1.77B
| $8.25M | ﹤0.01% |
129,285
-51,523
| -28% | -$3.13M |
|
|
NEE.PRR
2015
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $8.24M | ﹤0.01% |
207,468
-3,468
| -2% | -$139K |
|
|
BLD
2016
DELISTED
TopBuild
BLD
| $8.24M | ﹤0.01% |
25,460
-1,384
| -5% | -$411K |
|
2017
Option Care Health
OPCH
$3.61B
| $8.22M | ﹤0.01% |
253,180
+69,106
| +38% | +$2.23M |
|
|
JNPR
2018
DELISTED
Juniper Networks
JNPR
| $8.22M | ﹤0.01% |
205,765
-721
| -0.3% | -$25.8K |
|
2019
Genworth Financial
GNW
$3.7B
| $8.21M | ﹤0.01% |
1,055,199
+4,648
| +0.4% | +$32.5K |
|
2020
Ocular Therapeutix
OCUL
$2.14B
| $8.21M | ﹤0.01% |
884,381
+520,138
| +143% | +$4.07M |
|
2021
Nomad Foods
NOMD
$1.59B
| $8.21M | ﹤0.01% |
482,993
-199,373
| -29% | -$3.66M |
|
2022
Fidelity Enhanced Small Cap Core ETF
FESM
$6.29B
| $8.19M | ﹤0.01% |
256,131
+152,392
| +147% | +$4.53M |
|
2023
Nextpower Inc
NXT
$15.9B
| $8.18M | ﹤0.01% |
150,480
-7,154
| -5% | -$359K |
|
2024
First Trust Indxx NextG ETF
NXTG
$562M
| $8.18M | ﹤0.01% |
84,090
+198
| +0.2% | +$17.6K |
|
2025
Maplebear
CART
$11.4B
| $8.18M | ﹤0.01% |
180,807
+22,179
| +14% | +$964K |
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,185 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,185 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.